News and Announcements
GlaxoSmithKline Extends Service Agreement with MedAdvisor
- Published June 16, 2016 2:19PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th June 2016, ASX Announcement
Highlights
- GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months.
- GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio.
- Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and Adherence Campaigns (MTAC), revenue for MedAdvisor.
- Allows GKS Australia to leverage the MedAdvisor platform to support patients on the safe and effective use of these medicines.
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that the Australian arm of leading global pharmaceutical company, GlaxoSmithKline Australia Pty (GSK) has extended its services agreement with MedAdvisor for a further 12 months.
Under the agreement, GSK Australia will continue providing tailored messages to patients prescribed medicines with GSK Australia’s respiratory portfolio.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
